Ocugen Nears Regulatory Milestone with Key Gene Therapy Trial
Biotechnology firm Ocugen has completed patient enrollment for the pivotal Phase 3 clinical trial of its lead candidate, OCU400, a...
Biotechnology firm Ocugen has completed patient enrollment for the pivotal Phase 3 clinical trial of its lead candidate, OCU400, a...
Coinbase Global, Inc. is experiencing a notable uplift driven by concurrent developments in the political arena and its own service...
Oracle finds itself at a pivotal moment. The technology giant is navigating a complex landscape defined by a massive cloud...
The healthcare giant Johnson & Johnson is pursuing a dual strategy to enhance patient access and advance its pipeline. In...
The enterprise software firm Workday is charting a course through uncertain waters. While its latest annual financial performance demonstrated considerable...
At a major industry conference, ServiceNow’s leadership provided fresh details on its expanding artificial intelligence platform, signaling a strategic acceleration....
Heidelberg Materials has reported the strongest financial performance in its history, yet investors responded by selling off the stock. Instead...
A notable shift is occurring among major investment firms, with several significantly increasing their stakes in industrial gases giant Linde....
Investors in luxury goods are confronting a challenging period. A sharp sell-off has gripped the sector, with industry leader LVMH...
The proposed acquisition of German steel distributor Klöckner & Co by US-based Worthington Steel has entered a decisive and uncertain...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com